"Comprehensive Cancer Centers, an affiliate of The US Oncology Network, is an award-winning multispecialty practice comprising medical oncology, hematology, radiation oncology, breast surgery, pulmonary medicine, cancer genetic counseling and clinical research."

During the past decade, Comprehensive Cancer Centers of Nevada CCC of Nevada (1) conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 4 clinical trials were completed, i.e. on average, 200% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 3 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Comprehensive Cancer Centers of Nevada CCC of Nevada (1)" are "CML" (1 trials), "Chronic Myelogenous Leukemia Chronic Phase(CML-CP) Patients With Low Imatinib Trough Levels" (1 trials), "Hematologic Malignancies" (1 trials), "Metastatic Renal Cell Carcinoma" (1 trials) and "Philadelphia Chromosome Positive (Ph+)" (1 trials). Many other conditions were trialed in "Comprehensive Cancer Centers of Nevada CCC of Nevada (1)" in a lesser frequency.

Most popular intervention types in "Comprehensive Cancer Centers of Nevada CCC of Nevada (1)" are "Drug" (4 trials). Other intervention types were less common.

The name of intervention was led by "Ceritinib" (1 trials), "Dovitinib" (1 trials), "LGX818" (1 trials), "Sorafenib" (1 trials) and "nilotinib" (1 trials). Other intervention names were less common.

The vast majority of trials in "Comprehensive Cancer Centers of Nevada CCC of Nevada (1)" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Comprehensive Cancer Centers of Nevada CCC of Nevada (1)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Comprehensive Cancer Centers of Nevada CCC of Nevada (1), undefined suspended trials, and 3 terminated clinical trials to date.

Out of the total trials that were conducted in Comprehensive Cancer Centers of Nevada CCC of Nevada (1), 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".